Esperoct® (antihemophilic factor (recombinant), glycopegylated-exei)
for Hemophilia

Esperoct (antihemophilic factor (recombinant), glycopegylated-exei) is a long-lasting factor VIII replacement therapy for adults and children with hemophilia A. It helps control active bleeding, prevent surgical bleeding, and reduce bleeding episodes by temporarily replacing missing factor VIII. Its glycopegylation with polyethylene glycol extends its duration, offering prolonged protection.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia